Benitec Biopharma Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Benitec Biopharma Limited with three other
companies in this sector in AUSTRALIA :
sales of 23.40 million Australian Dollars [US$14.03 million]
of which 100%
was Mesenchymal Precursor Cell),
(12.55 million Australian Dollars [US$7.52 million]
of which 48%
was New Drug Development), and
Idt Australia Limited.
(12.13 million Australian Dollars [US$7.27 million]
Sales increased substantially in 2019:
Benitec Biopharma Limited reported sales of A$16.60 million (US$9.95 million)
June of 2019.
increase of 259.4%
versus 2018, when the company's sales were A$4.62 million.